Table 2.
Demographic characteristics of the participants
| Supplementation group (n = 103) | Placebo group (n =112) | P | |
|---|---|---|---|
|
Mean age in years |
37+/-13 |
37.1+/-13 |
0.869 |
|
Number of females n (%) |
70 (68.0) |
71 (63.4) |
0.566 |
|
Education n (%) |
|
|
|
|
Primary |
73 (70.9) |
88 (78.5) |
|
|
Secondary or better |
30 (29.1) |
24 (21.4) |
0.333 |
|
Mean Body Mass Index (kg/m
2
) |
22.6+/-3.8 |
22.8+/-5.9 |
0.581 |
|
HIV positive n = 66 (%) |
32 (48.4) |
34 (51.5) |
0.592 |
|
Mean Middle Upper Arm Circumference (MUAC) |
27.3+/-3.3 |
27.4+/-4.2 |
0.705 |
|
Mean Body fat (kg) |
29.9+/-9.4 |
29.5+/-9.8 |
0.547 |
|
Mean Lean mass (kg) |
70.0+/-9.3 |
69.9+/-11.0 |
0.630 |
|
Median (IQR) follow up (months) |
18 (16–19) |
19 (18–20) |
0.0001 |
|
pH n = 121 |
3.3+/-2.2 |
3.2+/-2.2 |
0.881 |
|
Tobacco use n (%) |
15 (14.5) |
23 (20.5) |
0.286 |
|
Cannabis n (%) |
4 (3.8) |
2 (1.8) |
0.430 |
|
Alcohol n (%) |
|
18 (16.1) |
|
|
Everyday |
12 (11.6) |
18 (16.1) |
|
| Not every day | 39 (37.9) | 33 (29.5) | 0.661 |